Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Compugen Ltd Azrieli Center 26 Harokmim Street Building D Holon L3 5885849 ISR

www.cgen.com P: 972-3765-8585 F: 972-376-5855

Description:

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.

Key Statistics

Overview:

Market Capitalization, $K 220,028
Enterprise Value, $K 205,768
Shares Outstanding, K 86,625
Annual Sales, $ 33,460 K
Annual Net Income, $ -18,750 K
Last Quarter Sales, $ 33,460 K
Last Quarter Net Income, $ 9,710 K
EBIT, $ -12,990 K
EBITDA, $ -12,790 K
60-Month Beta 2.65
% of Insider Shareholders 9.50%
% of Institutional Shareholders 12.22%
Float, K 78,396
% Float 90.50%
Short Volume Ratio 0.43

Growth:

1-Year Return 250.44%
3-Year Return -71.07%
5-Year Return -36.02%
5-Year Revenue Growth 87.98%
5-Year Earnings Growth 48.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.11 on 03/05/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 200.00%
EPS Growth vs. Prev Year 375.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 151.80
Price/Earnings to Growth N/A
Return-on-Equity % -30.01%
Return-on-Assets % -21.41%
Profit Margin % -56.04%
Debt/Equity 0.00
Price/Sales 6.47
Price/Cash Flow N/A
Price/Book 3.34
Book Value/Share 0.76
Interest Coverage -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar